Livongo Health, Inc. Reports Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2019; Provides Earnings Guidance for the Fourth Quarter and Full Year of 2019
For the nine months, Revenue was $119,605,000 against $47,225,000 reported a year ago. Loss from operations was $52,349,000 against $21,871,000 reported a year ago. Net loss was $48,916,000 against $20,922,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $1.34 against $1.29 reported a year ago.
For the fourth quarter, the company expects revenue in the range of $49.0 million and $49.5 million.
For 2019, the company expects revenue in the range of $168.5 million and $169.0 million.